Summit therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

Miami--(business wire)---- $smmt--summit therapeutics inc. (nasdaq: smmt) ("summit," "we," or the "company") today announced the grant of inducement awards of options to purchase a collective total of up to 200,000 shares of common stock. an award was made to one new employee of the company. the award was granted as an inducement material to the new employee becoming an employee of the company in accordance with nasdaq listing rule 5635(c)(4) and has been approved by the company's compensation committee.
NDAQ Ratings Summary
NDAQ Quant Ranking